![](/wp-content/themes/yootheme/cache/a0/Missouri-a0f380e7.jpeg)
Local Cdiff information for Missouri
Missouri
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Missouri.
Local Cdiff information for Missouri
Missouri
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Missouri.
![](/wp-content/themes/yootheme/cache/a0/Missouri-a0f380e7.jpeg)
Providers
Dr. Jason G. Newland MD, MEd
Associate Professor of Pediatrics
St. Louis Children’s Hospital
1 Childrens Place
St. Louis, 63110
314-454-6050
FMT Provider: No
Dr. Wilfred Lee, MD
Cape Gastroenterology Specialists
28 S Mount Auburn Road
Cape Girardeau, 63701
(573) 331-3350
FMT Provider: Yes
Dr. Erik R. Dubberke, MD, MSPH
Associate Professor, Medicine, Division of Infectious Diseases
Washington University Infectious Diseases
620 S Taylor Ave
St. Louis, 63110
(314) 747-1206
FMT Provider: Yes
Regulation
C. diff Infections
Total Reported Cases: 1831
Hospital Onset: 1831
Community Onset: Not reported
Related Deaths: Not reported
Available Reports
Available Reports
State Reporting Laws
Data Submission Required: No
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
State Contact
Eric Hueste, Chief
Missouri Department of Health and Senior Services
930 Wildwood Drive
Jefferson City, 65102
573-751-6113
573-526-0235
CLINICAL TRIALS
Animal-Assisted Visitation Program Chlorhexidine Trial
Official Title: Clinical Trial of a Disinfectant Intervention in Therapy Dogs to Combat Hospital-associated Pathogens and Promote Sustainability of Animal-Assisted Visitation Programs
Trial No. NCT04171817
Type: Interventional
Recruitment: Recruiting
Sponsor: Johns Hopkins Bloomberg School of Public Health
Contact: Meghan F Davis, DVM PhD
Gender: All
Age: 2 Years to 17 Years
RESTORATiVE303
Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.
To Understand the Safety and Effects of a C. Difficile Vaccine
Official Title: A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, Immunogenicity, and Immunopersistence of a Clostridioides Difficile Vaccine
Trial No. NCT05805826
Type: Interventional
Recruitment: Recruiting
Sponsor: Pfizer
Contact: Pfizer CT.gov Call Center
Trial No. NCT05805826
Type: Interventional
Recruitment: Recruiting
Sponsor: Pfizer
Contact: Pfizer CT.gov Call Center
Gender: All
Age: 65 Years and older
C.Difficile Observational Study
Official Title: An Observational Study in Adults With Clostridioides Difficile Infection to Determine the Feasibility and Logistics of Biospecimen Collection, Transportation and Testing at Select US Study Sites
Trial No. NCT06277999
Type: Observational
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: AstraZeneca Clinical Study Information Center
Type: Observational
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: AstraZeneca Clinical Study Information Center
Gender: All
Age: 18 Years and older